DEA removes cannabis drug Epidiolex from controlled substance list

Hemp Industry Daily
By John RebchookApr 7, 2020, 4:09 pm265 pts
Epidiolex, the only plant-derived cannabis drug approved by the U.S. Food and Drug Administration, is no longer considered a controlled substance, providing a boost to its manufacturer’s stock price. GW Pharmaceuticals, a biopharmaceutical company based in London, saw its stock go up 5.9% on Tuesday, one day…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Texas Governor Vetoes Ban on Hemp Products, Calls For Special Session to Regulate THC 67

Jesce Horton Balances Culture, Equity, and Enterprise 67

Senator offers timeline for major marijuana bill 62

Rick Steves Talks Travel, Cannabis and Freedom 61

Texas gov. makes final hour decision on hemp ban 59

What is Leafly’s queer staff smoking this Pride? 51

Pura Vida! Costa Rica officially starts medical cannabis rollout after years of delays 44

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.